AXIM (AXIM Biotechnologies) Long-Term Debt: $7.44 Mil (As of Jun. 2025)


What is AXIM Biotechnologies Long-Term Debt?

AXIM Biotechnologies AXIM Long-Term Debt is $7.44 Mil as of Jun. 2025. The stock has 7 warning signs investors should review.

AXIM Biotechnologies's Long-Term Debt for the quarter that ended in Jun. 2025 was $7.44 Mil.

AXIM Biotechnologies's quarterly Long-Term Debt increased from Dec. 2024 ($7.04 Mil) to Mar. 2025 ($7.24 Mil) and increased from Mar. 2025 ($7.24 Mil) to Jun. 2025 ($7.44 Mil).

AXIM Biotechnologies's annual Long-Term Debt increased from Dec. 2022 ($5.65 Mil) to Dec. 2023 ($5.66 Mil) and increased from Dec. 2023 ($5.66 Mil) to Dec. 2024 ($7.04 Mil).

AXIM Biotechnologies  (OTCPK:AXIM) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

AXIM Biotechnologies Long-Term Debt Related Terms

AXIM Biotechnologies Long-Term Debt Historical Data

* Premium members only.

The historical data trend for AXIM Biotechnologies's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AXIM Biotechnologies Long-Term Debt Chart

AXIM Biotechnologies Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.84 5.06 5.65 5.66 7.04

AXIM Biotechnologies Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.46 6.60 7.04 7.24 7.44
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of $7.44 Mil mean?
AXIM Biotechnologies (AXIM) has a Long-Term Debt of $7.44 Mil as of Jun. 2025.
Is AXIM Biotechnologies' Long-Term Debt too high?
AXIM Biotechnologies' current Long-Term Debt is $7.44 Mil.
How does AXIM Biotechnologies' Long-Term Debt compare to HEPA and SCNI?
AXIM Biotechnologies' Long-Term Debt of $7.44 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Biotechnology company?
A good Long-Term Debt depends on the Biotechnology industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. AXIM Biotechnologies's current Long-Term Debt is $7.44 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AXIM Biotechnologies stock overvalued right now?
AXIM Biotechnologies (AXIM) has a current Long-Term Debt of $7.44 Mil. The current Long-Term Debt is $7.44 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For AXIM Biotechnologies (AXIM), the current Long-Term Debt is $7.44 Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

AXIM Biotechnologies Business Description

Address 6048 Cornerstone Court West, Suite E1, San Diego, CA, USA, 92121
AXIM Biotechnologies Inc is a integrated research and development company and developer of diagnostic healthcare solutions serving to enhance the health of people. The company focuses on improving the landscape for the diagnosis of ophthalmological conditions such as Dry Eye Disease through rapid diagnostic tests. Additionally, The company owns IP and has conducted research on SARS-CoV-2 (COVID-19) rapid neutralizing antibody tests to detect levels of functional neutralizing antibodies that are believed to prevent SARS-CoV-2 from entering the host cells.